Recall Z-2539-2016— TYRX Inc.

Class II · Terminated

Class II FDA medical device recall by TYRX Inc., initiated 2016-06-29, terminated 2017-12-12. It names one FDA 510(k) clearance: K063091. Product: TRYX Antibacterial Envelope Rx Only Product Usage: Indicated for stabilization of implanted pacemakers (IPG) and/or implantable cardioverter defibrillators (ICD). Reason: TRYX products are being recalled since the processes of spaying, welding, drying oven and polymer were not adequately validated..

Recalling firm
TYRX Inc.
Classification
Class II
Status
Terminated
Initiated
2016-06-29
Terminated
2017-12-12
Firm location
Monmouth Junction, NJ, United States

510(k) clearances named in this recall

1 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

TRYX Antibacterial Envelope Rx Only Product Usage: Indicated for stabilization of implanted pacemakers (IPG) and/or implantable cardioverter defibrillators (ICD)

Reason for recall

TRYX products are being recalled since the processes of spaying, welding, drying oven and polymer were not adequately validated.

Data sourced from openFDA. This site is unofficial and independent of the FDA.